Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China flag China · Delayed Price · Currency is CNY
13.49
-0.15 (-1.10%)
Feb 13, 2026, 3:04 PM CST

SHE:000403 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21
Cash & Equivalents
575.91,3211,4291,001885.67102.83
Trading Asset Securities
658.87282.7423.34422.44234.21-
Cash & Short-Term Investments
1,2351,6041,8531,4231,120102.83
Cash Growth
-29.62%-13.43%30.18%27.09%989.09%-7.32%
Accounts Receivable
768.44668.99592.77891.08581.12314.17
Other Receivables
7.5348.242.3449.7112.835.75
Receivables
775.98717.19635.11940.79593.95319.93
Inventory
1,7311,233909.37623.69738.97441.76
Prepaid Expenses
-0.060.30.1401.76
Other Current Assets
33.3524.6328.659.1216.536.44
Total Current Assets
3,7753,5793,4263,0472,469872.71
Property, Plant & Equipment
2,0631,9991,5541,2971,103410.91
Long-Term Investments
66----
Goodwill
2,6152,6152,6152,6152,615-
Other Intangible Assets
190.25200.33212.59192.52200.0565.46
Long-Term Deferred Tax Assets
33.0629.4349.0449.0927.3511.75
Long-Term Deferred Charges
223.03153.5579.4789.767.4236.04
Other Long-Term Assets
669.88664.24694.87692.81605.82282.85
Total Assets
9,5759,2468,6307,9827,0881,680
Accounts Payable
127.19224.26154.35158.37158.738.32
Accrued Expenses
28.76334.84372.84373.49239.21171.81
Short-Term Debt
758.64310.49250.57275.1113.52332.41
Current Portion of Long-Term Debt
63.4417.0621.228.63--
Current Portion of Leases
-5.066.677.147.055.28
Current Income Taxes Payable
43.2319.0739.7243.0824.2218.31
Current Unearned Revenue
3.156.3610.7625.9111.545.2
Other Current Liabilities
262.1639.8466.0667.5888.0474.19
Total Current Liabilities
1,287956.97922.19959.31642.29645.51
Long-Term Debt
197.26303.22196.0852.89-20.02
Long-Term Leases
12.6918.621.4829.5920.8922.33
Long-Term Unearned Revenue
37.0826.8435.640.0849.2415.95
Long-Term Deferred Tax Liabilities
12.7914.1324.2630.3336.52-
Other Long-Term Liabilities
9.6399911.149
Total Liabilities
1,5561,3291,2091,121760.07712.82
Common Stock
950.4731.07733732.39732.92492.43
Additional Paid-In Capital
4,539--4,7794,77952.56
Retained Earnings
2,5372,4351,9461,392846.23455.3
Treasury Stock
---43.17-36.22-32-34.98
Comprehensive Income & Other
0.054,7584,7930.04-0-
Total Common Equity
8,0267,9257,4296,8686,326965.32
Minority Interest
-6.78-7.15-6.79-6.42.071.59
Shareholders' Equity
8,0197,9187,4226,8616,328966.91
Total Liabilities & Equity
9,5759,2468,6307,9827,0881,680
Total Debt
1,032654.44496.02373.36141.46380.04
Net Cash (Debt)
202.74949.391,3571,050978.42-277.21
Net Cash Growth
-82.50%-30.02%29.22%7.30%--
Net Cash Per Share
0.221.001.431.101.06-0.43
Filing Date Shares Outstanding
950.4950.4950.06952.1952.8951.65
Total Common Shares Outstanding
950.4950.4950.34952.1952.8640.17
Working Capital
2,4882,6222,5042,0881,827227.2
Book Value Per Share
8.448.347.827.216.641.51
Tangible Book Value
5,2215,1104,6014,0603,511899.86
Tangible Book Value Per Share
5.495.384.844.263.681.41
Buildings
-1,180833.6701.14583.25261.01
Machinery
-1,184961.1920.37729.45324.38
Construction In Progress
-513.36582.7385.73334.3832.73
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.